课题基金 / 基金详情

Elucidation of the cell cycle checkpoint mechanisms in mammalian cells

Elucidation of the cell cycle checkpoint mechanisms in mammalian cells
阐明哺乳动物细胞的细胞周期检查点机制
批准号:
11470035
负责人:
NAKANISHI Makoto
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

NAKANISHI Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The transmission of genetic information relies on checkpoint responses to errors affecting the integrity, replication, and segregation of the genome. A defect in checkpoint mechanisms can result in genetic instability and lead to the transformation of normal cells into cancer cells. Many genes that contribute to checkpoint mechanisms were initially identified in fission or budding yeast as a result of mutations that disrupt cell cycle checkpoints, and the recent discovery of their mammalian counterparts has suggested the conservation of checkpoint mechanisms between yeast and mammals. In fission yeast, the protein kinases Chk1 and Cds1 cooperatively function in cell cycle arrest upon DNA damage through regulating Cdc25. However, the functions of these kinases in mammals have remained unknown. Targeted disruption of Chk1 and Cds1 genes in mice revealed that Chk1-/- mice exhibited early embryonic lethality before E7.5 and its embryos exhibit gross morphologic abnormalities in nuclei as early as the blastocyst stage. DNA replication block and DNA damage failed to arrest the cell cycle before initiation of mitosis in Chk1-/- embryos. Thus, Chk1 is indispensable for cell proliferation and survival through maintaining the G2/M checkpoints in mammals. In contrast, Cds1-/- mice were viable and fertile, and its MEFs did not show the remarkable defects in G2/M checkpoints. Alternatively, Cds1-/- thymocytes were resistant to IR-induced and p53-dependent apoptosis. Taken together, these results clearly suggest that, in mammals, Chk1 and Cds1 kinases play important roles in distinct signal pathways upon DNA damage through regulating Cdc25 and p53, respectively.
期刊论文(119)
专著(0)
科研奖励(0)
会议论文
Fuse,T.: "p27^<Kip1> expression by contact inhibition as a prognostic index of human glioma."J.Neurochem.. 74. 1393-1399 (2000)
Fuse,T.:“接触抑制的 p27^<Kip1> 表达作为人类神经胶质瘤的预后指标。”J.Neurochem.. 74. 1393-1399 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mitsui,K: "A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins."Biochem.Biophys.Res.Commun.. 266. 115-122 (1999)
Mitsui,K:“编码 HECT 结构域和 RCC1 样重复序列的新型人类基因与细胞周期蛋白相互作用,并可能受到肿瘤抑制蛋白的调节。”Biochem.Biophys.Res.Commun.. 266. 115-122 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
46
    Development of a New Synthesis Method Mimicking Iron-oxidizing Bacteria for Highly Chromatic Inorganic Pigments
    • 批准号:
      20K21238
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.08万
    • 财政年份:
      2020
    • 负责人:
      NAKANISHI Makoto
    • 依托单位:
    Establishment of damage dose-dependent senescence inducible system and its application for understanding molecular basis underlying geriatiric diseases
    • 批准号:
      24659137
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NAKANISHI Makoto
    • 依托单位:
    Mechanism of premature senescence induction through DNA damage responses
    • 批准号:
      23240124
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.62万
    • 财政年份:
      2011
    • 负责人:
      NAKANISHI Makoto
    • 依托单位:
    A study on teaching haiku to nurture aesthetic sensitivity and communication competence
    • 批准号:
      23531208
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.08万
    • 财政年份:
      2011
    • 负责人:
      NAKANISHI Makoto
    • 依托单位:
    国内基金
    海外基金
    NK细胞抑制性受体CD96作为肝癌checkpoint免疫治疗靶点的进一步验证
    • 批准号:
      81972679
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2019
    • 负责人:
      孙昊昱
    • 依托单位: